Interferon-.epsilon.
US6329175A · kind A · utility
2Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 1999 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Sep 16, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/555
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. To date, four types of interferons have been found in humans: interferon-.alpha., interferon-.beta., interferon-.gamma., and interferon-.omega.. The present invention provides new forms of human and murine interferon, "interferon-.epsilon.," which have applications in diagnosis and therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.